Alzheimer's disease (AD) is the most common cause of dementia in the aged population and is the fourth leading cause of death in the western world. T h e disease is characterized clinically by the progressive loss of memory and intellect. Pathologically, this cognitive decline is associated with the appearance in the brain of extracellular amyloid plaques and intracellular abnormalities of tau protein leading to the formation of neurofibrillary tangles.
Amyloid, otherwise known as AD, is a 39-43 amino acid peptide that is excised from a larger type I transmembrane protein, the amyloid precursor protein (APP), by the sequential action of two proteolytic activities, known as P-secretase and y-secretase. T h e heterogeneity in the size of AP is predominantly due to alternative C-terminal cleavages by y-secretase. The identities of the APP secretases, and the function of APP, remain to be discovered, although both growth factor and neuroprotective roles for the secreted extracellular domain (known as secreted APPa) have been described [1, 2] .
There is now a large body of evidence from a variety of sources that supports the so-called 'amyloid hypothesis' -that the production and subsequent deposition of AP is a key aetiological event in the development of the disease [3] . The most persuasive data have been derived from the genetics of AD. A recent twin study showed pairwise concordance rates for AD of 19% and 5% for monozygotic and dizygotic twins respectively, emphasizing the considerable contribution of genetic factors to disease manifestation [4] . In the past, AD has been rather arbitrarily divided into early onset AD (sufferers below the age of 60 years) and late onset AD (sufferers over the age of 60 years). Early onset AD is sometimes taken to be synonymous with familial AD (FAD) in which, according to various criteria, the disease is judged to run in families. A further complication is that some of the familial cases are subcategorized into autosomal dominant Abbreviations used: AD, Alzheimer's disease; APP, amyloid precursor protein; FAD, familial AD; EOFAD, early onset FAD; PS, presenilin; PS-1, presenilin-1; PS-2, presenilin-2.
FAD, where the propensity to develop the disease segregates in the appropriate manner. Notwithstanding these difficulties in definition, about 5% of all AD cases can be classified as autosomal dominant, early onset familial AD (EOFAD).
One breakthrough in AD research, and one of the cornerstones of the amyloid hypothesis, was the discovery that in a small number of families, mis-sense mutations located either side of the AP sequence within the APP gene led to EOFAD. Subsequently, it was realized that mutations to the APP gene, located on chromosome 21 at 21q21.1, actually accounted for very few of the EOFAD cases, with approximately 70% of EOFAD cases being linked to a gene on chromosome 14 (although recent data suggest that this figure was a considerable over-estimate [S] ). This led to the discovery, by positional cloning, of the gene encoding presenilin-1 (PS-1) which is located on chromosome 14 (14q24.3). Database searching led to the discovery and subsequent identification of a homologous gene, presenilin-2 (PS-2), located on chromosome 1 (lq41.2), that was responsible for EOFAD in the so-called Volga German families. T o date, 46 EOFAD mutations at 36 codons have been described for PS-1, and two mutations at two codons have been described for PS-2 (Table 1) . In general, PS-2 FAD mutations cause AD with a later age of onset than PS-1 mutations [6] , and as a consequence it is possible that PS-2 FAD mutants remain to be discovered among patients with late onset AD.
Presenilin cell biology
PS-1 is a 467 amino acid protein with 10 hydrophobic domains [7] . PS-2 is a 448 amino-acid protein that is 67% identical to PS-1 [8] . Most of the diversity between the two proteins resides in the N-terminal and hydrophilic loop domains: the hydrophobic domains are very well conserved. Several studies have been performed to elucidate the membrane topology of PS-1. This information is critical to understanding the functionality of PS-1 (and by implication, PS-2) as it delineates the orientation of the various regions of the protein across the membrane which, in turn, dic-tates the availability of protein domains to make either lumenal or cytosolic protein-protein interactions. Given the current data, the best model, based on studies performed with PS-1 and its Caenorhabditis elegans homologue sel-12, is that TM2  TM2  TM2  TM2  TM3  H L3  TM4  TM4  TM5  TM5  TM6  TM6  TM6  TM6  TM6  H L6  H L6  H L6  H D7  H D7  HD7/large HL  Large HL  Large HL  TM7  TM7  TM8  TM8  H D9   TM2  TM5 *TM, transmembrane domain; HD, hydrophobic domain; HL, hydrophilic loop.
PS-1 adopts an eight transmembrane configuration, where the hydrophilic loop and the N-and C-termini are oriented towards the cytoplasm ( Figure 1 ) [9, 10] . Most studies have suggested that the protein resides predominantly within the endoplasmic reticulum [ 1 1,121, although there have been reports that PS-1 can be present at the cell membrane [13] and in the dendrites and cell bodies of neurons [14, 15] PS processing is a highly regulated process, and is therefore very likely to be biologically important. Thus, over-expression of PS leads to a build up of holoprotein, indicating that the endoproteolytic step is rate-limiting in these circumstances. In turn, the levels of .the cleaved PS fragments are also regulated, such that the overexpression of human PS-1 in a mouse cell line leads to replacement of the endogenous PS fragments with human equivalents [24] .
How PS processing relates to its functionality has not been elucidated, and neither has the wider question of whether the holoprotein or the cleaved fragments, or both, play important biochemical roles.
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Functionality of presenilins
Investigations into the role of the presenilins, and more particularly their involvement in the pathogenesis of AD, currently fall into a number of experimental areas. Whatever hypothesis is posited for their functionality must account for the fact that mutations throughout PS-1 -lying on both sides of the endoproteolytic cleavage site -all produce EOFAD. Thus, the functional form of PS most probably involves either the holoprotein or a complex of the N-and C-terminal fragments. 
APP processing
Presenilin-1
Presenilin-2 Presenilin-2 y-secretase cleavage site remains unanswered, although some important experimental findings have been recently published.
Firstly, it has been demonstrated that both PS-1 and PS-2 can be co-immunoprecipitated with APP [29,30]. Interestingly, it was the Nglycosylated, immature APP molecule that coimmunoprecipitated with the PS holoprotein. This is consistent with the interaction occurring within the endoplasmic reticulum. Another very significant finding is that in embryonic neurons derived from PS-1 knockout mice, y-secretase activity was decreased by about 80% [31] . This argues in favour of PS-1 playing a role in regulating y-secretase activity: indeed, it could be that a macromolecular complex consisting of presenilin, APP and y-secretase forms across the endoplasmic reticulum membrane and controls the fate of APP. Further, it could be postulated that all of the mutations in PS are able to change subtly the conformation of the protein in the membrane and thereby alter the apposition of APP to y-secretase -in turn altering the position of the cleavage. If this were true, an extension of this hypothesis would be that APP FAD mutations at the C-terminus of the A/) sequence in APP would likewise alter the conformation of the PS-APP-y-secretase complex with a similar outcome. Of interest in this regard is the observation that, in differentiated neurons, would appear to be produced predominantly within the endoplasmic reticulum [ 321.
Cell signalling
Lin-12 is a C. elegans homologue of the notch receptor family that is involved in cell fate determination. Levitan and Greenwald made a key observation when they were seeking C. elegans mutants that reverted a multivulva phenotype caused by expression of a hypermorphic lin-12 mutant [33] . From this screen, two mutants of a gene named sel-12 (sel means suppressor or enhancer of lin-12) were identified: sel-12 is the closest homologue of PS, possessing about 50% identity. Sel-12 mutants alone caused an egglaying deficiency.
Subsequent work in this system has revealed that human PS-1 and PS-2 are able to restore normal function (as measured by rescue of the egg-laying defect), in contrast with the FAD PS-1 point mutants, which had greatly reduced activity [34, 35] . T h e exception was the exon 9 splice acceptor site mutation, which was able to restore most of the functionality of PS. It has also been confirmed that, like the PS proteins, sel-12 is normally endoproteolytically cleaved within cells in a similar position to that of the PSs [lo]. C. elegans remains an attractive model system with which to explore the functionality of the presenilins. However, considerable work needs to be performed before the effects of PS FAD mutants in C. eleguns can be linked biochemically with their effects in mammalian cells to alter the production of AP42.
The association between notch and PS can also be inferred from the similar phenotypes induced by PS-1, notch-1 and Dlll knockout mice (Dlll is a notch ligand). PS-1 homozygous knockout mice die either in utero or shortly after birth. They suffer from intra-cranial haemorrhage, neuronal loss and severe malformation of the skeleton [36,37], as well as defective somite segmentation, which is also seen in notch-1 and Dlll knock-out mice [38, 39] . In PS-1 knock-out mice, the levels of notch-I and D111 expression were markedly reduced [37] . Additionally, it has been shown in early mouse embryogenesis that the temporal and anatomical expression of notch-1 and the PSs is very similar, with levels being high firstly in the neuroepithelium followed by the ventricular zone from which brain cells are derived. In the adult, PS was detected strongly in the cerebellum and hippocampus, as was notch-1 Thus, there is a strong case to be made for an involvement between notch signalling and the PS proteins, at least during development. However, the relevance of these findings to the pathology of AD remains to be determined. T h e winglesslwnt signalling pathway, which like notch is involved in a range of cell development decisions, has also been demonstrated to interact with PS-1. Using the PS-1 loop region as a 'bait' in a yeast two-hybrid system, Zhou et A further fascinating observation is that glycogen synthase kinase, which is implicated in the phosphorylation of tau protein that may lead to neurofibrillary tangles in AD, is also part of the wnt signalling pathway [43] . It would be a highly significant finding if the two principal pathologies of AD could be linked within a common cellular signalling pathway.
Apoptosis
Although the contribution and importance of apoptosis to AD pathology has yet to be clarified, some important experimental observations have been made that strongly imply a role for the PSs in programmed cell death. A seminal observation was made by Vito [45] and that the N141I PS-2 FAD mutant increased basal apoptosis [46] . These apparently contradictory results were resolved by work showing that the ALG-3 fragment acted as a dominant inhibitor of apoptosis, and further that the C-terminal fragment of PS-2 that is generated by caspase-3 cleavage within the loop region of the protein is also anti-apoptotic. Also, there is evidence of alternative mRNA transcripts that encode PS-2 proteins similar in size to ALG-3 [47] . Thus, there is considerable evidence that PS-2 plays a regulatory role in apoptosis. Other workers have shown that during apoptosis, both PS-1 and PS-2 are cleaved within the loop region at caspase substrate consensus sequences [48] , with the N141I PS-2 mutant being more susceptible to cleavage.
Summary
T h e discovery of the PS proteins, the complexities of their biochemistry and their potential involvement in signalling pathways and in apoptosis have galvanized research into AD. T o date, the aspect of the functionality of the PSs most relevant to the pathology of AD is the effect of PS FAD mutants to increase the proportion of produced from cells. This, coupled to the observation that y-secretase cleavage is considerably reduced in neurons derived from PS-1 knockout mice, argues strongly that PS plays a very direct role in the proteolytic processing of APP.
